Injectable Steroids

Drosta P 100 mg Ortesa

Ortesa

55,00

In Stock (100 available)

Drosta P 100 mg Ortesa (100 mg) — Manufactured by Ortesa to exacting pharmaceutical standards, this pharmaceutical-grade injectable compound is formulated for optim…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost

Description

Drosta P 100 mg Ortesa — Drostanolone (Masteron) — DHT-derived cutting compound. Dry, hard look with mild anti-estrogen activity; stacks with tren and test. Each unit dosed at 100 mg.

Key Benefits

  • DHT-derivative — dry, hard, vascular look with no water retention
  • Anti-estrogenic side-activity — mild AI effect
  • Cutting and pre-contest staple, especially at low body-fat
  • Minimal sides at performance doses — clean compound
  • Stacks well with tren, test, and orals for cutting recomp
  • Each unit dosed at 100 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: propionate 300–500 mg/week split EOD or 3×/week; enanthate 400–600 mg/week split twice weekly. Cycles 8–10 weeks (prop) or 10–14 weeks (eno). Pre-contest protocols stretch to final 6 weeks before show.

How It Works

5α-reduced testosterone with a 2α-methyl group. DHT-derivative — does not aromatise. Mild anti-estrogenic activity via aromatase enzyme competition. High AR affinity. Androgenic but not aggressively so at typical doses.

Pharmacokinetics

Propionate ester: plasma half-life ~2 days. Enanthate: ~7 days. Prop needs EOD or M/W/F pinning; eno twice-weekly fine. Steady-state in 2 weeks (prop) or 4 weeks (eno).

Potential Side Effects

Hair-thinning risk for genetically predisposed users — the DHT-derived nature makes it unfriendly to MPB. Oestrogenic sides absent. HDL drops moderately. Mild HPTA suppression recoverable with standard PCT.

Cycle & Stacking Guide

Cutting stack component, 8–14 weeks by ester. Classic pairing: test E 250 mg/week + masteron E 400 mg/week + (optional) tren or winstrol for final weeks. Works best at <15% body fat where the "dry" look actually shows.

Manufacturer Notes

Ortesa operates as a pharmaceutical-grade producer with documented GMP compliance. Their injectables use pharma-grade carriers with low allergy profile.

Storage & Handling

Store upright at 15–25 °C in the original box, protected from light and moisture. Oil-based injectables are shelf-stable for the duration printed on the vial when kept at controlled room temperature. Do not refrigerate — cold thickens the carrier oil and makes drawing/injecting harder. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Drosta P 100 mg Ortesa”

Your email address will not be published. Required fields are marked *